exfoliation syndrome as a risk factor for corneal endothelial cell loss in cataract surgery
TRANSCRIPT
O R I G I N A L A R T I C L E
Exfoliation Syndrome as a Risk Factorfor Corneal Endothelial Cell Lossin Cataract Surgery
KULDAR KALJURAND, MD,
PAIT TEESALU, MD, PhD A B S T R A C T
Purpose. To compare the influence of various cataractsurgery pre-, intra-, and postoperative characteristics tocornea endothelium and thickness in patients with andwithout exfoliation syndrome (PEX). Methods. In this pro-spective study 27 consecutive patients with and 26 patientswithout PEX as a control group scheduled for cataract sur-gery were studied. The corneal endothelial cells wereevaluated preoperatively and postoperatively at 1 day and1 month after surgery using noncontact specular micros-copy. Intraoperative parameters of operation time, phaco-emulsification (phaco) time, phaco power and amount ofbalanced salt solution (BSS) were recorded. The effects ofage, axial length, anterior chamber depth (ACD), and lensthickness were evaluated. Results. There were no signifi-cant preoperative differences in endothelium morphologybetween the two groups. The mean endothelial cell loss1 month after surgery was 18.1% in the PEX group and 11.6%in the control group (p = 0.06). Phaco time and used BSSvalues were significantly higher in patients with PEX but hadno significant influence on endothelial cell loss. In regressionanalysis phaco power (p = 0.02) and age (p = 0.004) had asignificant influence on endothelial cell loss. PEX in inter-action with overall phaco impact had a negative influence onendothelial cell loss (p = 0.05). Conclusions. PEX as a maineffect was not found to have a negative influence on endo-thelial cell loss. However, PEX in cases of high phaco impactsignificantly increases the risk of endothelial cell loss.
INTRODUCTION
The corneal endothelium is essential for maintenance
of normal corneal hydration. It consists of a mono-
layer of hexagonal cells, the density of which is
highest at birth and declines linearly with age (1,2).
This layer is highly vulnerable and has limited
regenerative capacity (3). Dysfunction of endothe-
lium results in corneal decompensation and decreased
vision. Exfoliation syndrome (PEX) is characterized
by the development of white, dundruff-like flakes
throughout the anterior ocular segments. It is well
known that the presence of PEX increases the
R E P R I N T SKuldar Kaljurand, MD, Department of Ophthalmology, University of Tartu,
J. Kuperjanovi 1, 51003, Tartu, Estonia. E-mail: [email protected].
Drs. Kaljurand and Teesalu are from the Department of Ophthalmology,
University of Tartu, Tartu, Estonia.
The authors have stated that they do not have a significant financial interest or
other relationship with any product manufacturer or provider of services dis-
cussed in this article. The authors do not discuss the use of off-label products,
which includes unlabeled, unapproved, or investigative products or devices.
The authors have no financial or proprietary interest in any material or method
mentioned.
Submitted for publication: 5/8/07. Accepted: 6/29/07.
Annals of Ophthalmology, vol. 39, no. 4, Winter 2007
� Copyright 2007 by ASCO
All rights of any nature whatsoever reserved.
1530-4086/07/39:327–333/$30.00. ISSN 1558-9951 (Online)
ANN OPHTHALMOL. 2007;39 (4) ..............................................327
incidence of intraoperative and postoperative com-
plications in cataract surgery (4–6). Although cata-
ract surgery in the long run decreases intraocular
pressure, the transient pressure peaks occurring in the
early postoperative period are more common in eyes
with exfoliation (7). Insufficient mydriasis and
weakened attachments of the zonular fibers to the
ciliary body predisposes these eyes to surgical com-
plications, with a five- to tenfold increase in the rate
of zonular breaks, capsular dialysis, or vitreous loss
(8–10). Fortunately only a minority of eyes with PEX
syndrome develop the aforementioned severe com-
plications, which lead to significant loss of corneal
endothelial cells. Wirbelauer et al. (11) found that
uncomplicated cataract surgery induces similar
endothelial cell changes in patients with PEX com-
pared with age-matched controls. However, there is
no agreement between studies if unoperated eyes with
PEX compared with no exfoliation have quantitative
or qualitative morphological changes in corneal
endothelium (11,12). Various preoperative factors
such as anterior chamber depth (ACD), axial length,
and age have been proposed to influence the severity
of endothelium damage (13–15). These various pre-
operative factors might have unequal power of sig-
nificance in patients with and without PEX in
interaction with intra- and postoperative factors. The
aim of this study was to evaluate the influence of
various cataract surgery pre-, intra-, and postopera-
tive characteristics on cornea endothelium and
thickness in patients with and without PEX.
PATIENTS AND METHODS
Thirty-seven consecutive patients scheduled for cata-
ract surgery (between March 2004 and December
2004) with PEX and 37 consecutive patients without
PEX as a control group (nonPEX) underwent pre-
operative ophthalmological examination, including
anterior segment biomicrosopy, binocular ophthal-
moscopy, and Goldmann applanation tonometry.
Previous ocular surgery, ocular trauma, high myopia,
history of uveitis, and abnormalities of the cornea
were exclusion criteria for the study. Patients with
mature cataract were not included in the study.
Nineteen patients with postoperative corneal oedema,
eight from the PEX and 11 from the nonPEX group,
were not included because of difficulties in endothelial
cell counting on the first postoperative day. Two pa-
tients from the PEX group with an endocapsular
ring placement were not included because this surgi-
cal maneuver might cause additional damage to
endothelium. None of the patients were contact-lens
wearers in their lifetime. All patients gave informed
consent, which was in accordance with the ethical
standards laid down in the Declaration of Helsinki.
The diagnosis of PEX was made after pupil dila-
tation with 1% cyclopentolate and 10% phenylephrine
hydrochloride. Exfoliative material was defined as
typical white-greyish material on the anterior surface
of the lens, on the corneal endothelium, and at the
pupil margin. The axial length, ACD, and lens
thickness were measured preoperatively by ultraso-
nography (Humphrey A/B scan system 837). Kera-
tometry was performed using an OAP211
keratometer (Carl Zeiss). Corneal endothelial cells
were photographed and corneal thickness was mea-
sured using an automatic noncontact specular
microscope (Topcon SP2000P). This device provides
rapid morphometric analysis and has reliable repro-
ducibility (16,17). Corneal endothelial cell density
(ECD), average cell area, and the coefficient of vari-
ation (CV) were recorded in the center of the cornea
and in four paracentral locations. The latter positions
were placed in the superior, inferior, temporal, and
nasal quadrants in a 6-mm-diameter circle, each po-
sition 3 mm from the center of the cornea. To
determine the endothelial cell density, the endothelial
cells were counted in a rectangular frame placed
manually with constant (0.1� 0.1 mm) area. Exam-
inations were made preoperatively, on the first post-
operative day and 4 weeks after surgery by the same
examiner (KK). The 4-week follow-up period was
considered to be sufficient because there are several
investigations suggesting that damage of corneal
endothelial cell is detectable already in the first post-
operative month (11,14,18,19).
All patients underwent phacoemulsification with-
out complications through a self-sealing limbal tunnel
incision. All operations were made using the same
phaco equipment (Protege, Storz Ophtahlmics) by
one experienced surgeon (PT). Topical anesthesia
with 2% oxubrucaine eye drops (Alcain, Alcon) and
the temporal approach was used in all cases. After the
circular continuous capsulorhexis (CCC) phacoe-
mulsification inside the capsular bag was performed.
After initial groove formation into the nucleus, the
chopping technique was used. Before CCC and
intraocular lens (IOL) implantation the viscoelastic
substance (Celoftal�, Alcon) was injected into the eye.
The wound was enlarged to 5 mm before the
implantation of the IOL (Bausch & Lomb, model
EZE-50). At the end of the operation the viscoelastic
material was removed from the anterior chamber as
ANN OPHTHALMOL. 2007;39 (4) ..............................................328
well as from behind the IOL. Postoperatively dexa-
methazone with chloramphenicol (Oftan DexaChl-
ora, Santen) drops were used five times daily for
3 weeks, and thereafter three times daily for 2 weeks.
Evaluated intraoperative factors were overall
operation time, elapsed phaco time, phaco power,
overall phaco impact (phaco time multiplied by phaco
power), and volume of balanced salt solution (BSS)
(Bausch & Lomb).
Statistics were performed using Student t-tests and
regression analysis. All data was analyzed using the
SAS software package (release 6.12, SAS Institute Inc.)
RESULTS
Mean patient age in the PEX group was 73 (range 51–
85) years ± 8.3 (SD) and in the nonPEX group was
68.1 (range 43–84) years ±8.0 (SD), (p = 0.02). Pre-
and postoperative visual acuities and the types of cat-
aract were similarly divided. Differences between the
two groups in mean axial length, ACD, lens thickness,
and keratometry were not significant. Pupil mean size
before dilatation and 24 hours after operation was
smaller in the PEX group, but not statistically signifi-
cantly so. Preoperative intraocular pressure (IOP) was
within the same range in both groups, but variability
was higher in the PEX group (Table 1). On the first
postoperative day IOP was higher in PEX group but
the difference between the groups did not reach sta-
tistical significance (24.8±11.7 vs. 19.7±6.0 mmHg,
p = 0.07), (Table 1). In regression analysis the pre-
and postoperative (24 hour) IOP, as the main effect,
did not influence central ECD (p = 0.9, p = 0.6 resp;
r2 = 0.47).
The mean preoperative ECD values, average cell
size, and thickness of cornea did not differ signifi-
cantly between the PEX and nonPEX groups (Ta-
ble 2). The mean preoperative corneal central ECD
was 2543 (±417) in the PEX group and 2594 (±519)
in the nonPEX group. The mean paracentral ECD
was 2479 (±422) in the PEX group and 2455± (475)
in the nonPEX group. Preoperative mean central
ECD values were higher than paracentral cell counts,
2.5% and 5.4%, respectively, in the PEX group and
nonPEX group.
We found a statistically significant difference in
paracentral but not central endothelial cell loss in the
first postoperative day between the PEX and nonPEX
groups (Table 2). The decrease of the central ECD
was 9.8% (p = 0.04) in the PEX group and 9.5%
(p = 0.04) in the nonPEX group. The decrease of the
paracentral ECD was 8.2% (p<0.001) in the PEX
group and 1.1% (p = 0.4) in the nonPEX group.
One month after the operation the cornea was more
affected centrally as well as paracentrally in the PEX
group than in the nonPEX group (Table 2). The
TABLE 1
Pre- and Postoperative Variables
Variable PEX group nonPEX group p
Age, years 73.5 (±8.3) 68.1 (±8.0) 0.02
Sex, F:M 19:8 20:6
Pupil, preop ø (mm) 3.6 (±0.6) 3.9 (±0.7) 0.1
Pupil, postop ø (mm) 4.8 (±0.9) 5.0 (±0.9) 0.4
IOP, preop, mmHg 17.6 (±4.5) 16.7 (±2.7) 0.4
IOP, postop (24 hour) 24.8 (±11.7) 19.7 (±6.0) 0.07
IOP, postop (1 month) 16.5 (±3.4) 17.3 (±5.4) 0.6
ACD, mm 2.98 (±0.4) 2.98 (±0.4) 0.9
Lens thickness, mm 4.4 (±0.6) 4.3 (±0.6) 0.7
Axial length, mm 23.2 (±0.7) 23.4 (±1.2) 0.5
Keratometry K1 43.5 (±1.6) K1 43.3 (±1.2) 0.7
K2 43.8 (±1.3) K2 43.1 (±1.3) 0.09
IOP = intraocular pressure.
ACD = anterior chamber depth.
ANN OPHTHALMOL. 2007;39 (4) ..............................................329
TA
BLE
2
Pre
-an
dPost
oper
ativ
eEn
doth
elia
lC
ell
and
Corn
eal
Thic
knes
sV
aria
ble
s
Variable
Regio
nof
corn
ea
Pre
op
PE
XP
reop
nonP
EX
pP
osto
p24
hour
PE
XP
osto
p24
hour
nonP
EX
pP
osto
p1
month
PE
XP
osto
p1
month
nonP
EX
p
ECD
±SD
(cell/mm
2)
Central
2543±
417
2594±
519
0.7
2293
�±
438
2347
�±
449
0.9
2083
�±
447
2344
�±
503
0.06
Paracent
2480±
422
2455±
475
0.7
2246
�±
525
2428±
509
0.01
2176
�±
486
2294
�±
546
0.09
Averagecellarea±
SD
(lm
2)
Central
401±
83
396±
86
0.5
455
�±
102
441
�±
90
0.7
500
�±
121
441±
90
0.4
Paracent
420±
95
434±
97
0.8
476
�±
156
430±
98
0.02
483
�±
122
454
�±
103
0.06
Coef.ofvariation±
SD
Central
22.4±
5.7
24.4±
7.6
0.3
25.5
�±
7.3
26.0±
5.8
0.8
24.1±
5.2
23.8±
7.0
0.8
Paracent
22.3±
5.3
23.7±
6.6
0.08
25.5
�±
7.1
25.6
�±
7.3
0.9
24.2
�±
6.0
24.3±
5.5
0.9
Cornealthickness±
SD
(mm)
Central
0.515±
0.031
0.520±
0.035
0.6
0.559
�±
0.041
0.553
�±
0.046
0.6
0.519±
0.035
0.523±
0.042
0.7
Paracent
0.515±
0.033
0.524±
0.035
0.6
0.556
�±
0.041
0.556
�±
0.060
0.9
0.520±
0.036
0.527±
0.038
0.2
EC
D=
endoth
elia
lcell
density.
SD
=sta
ndard
devia
tion.
para
cent
=para
centr
al.
�p
<0.0
5,
pre
op
vs.
posto
p24
hour.
�p
<0.0
5,
pre
op
vs.
posto
p1
month
.
ANN OPHTHALMOL. 2007;39 (4) ..............................................330
decrease of mean central corneal ECD compared with
preoperative values was 18.1% (p<0.001) in the PEX
group and 11.6% (p = 0.08) in the nonPEX group,
but the difference between the two groups had
a statistically weak significance (p = 0.06). The
decrease of mean ECD values in the paracentral part
had the same tendency but was less weaker (12.3% in
the PEX and 6.6% in the nonPEX group) and was not
statistically significant.
The average cell area was similar in the two groups
preoperatively, but was more increased in the PEX
group than in the nonPEX group 1 month after sur-
gery. The average increase in cell area was 99 lm2
centrally and 63 lm2 paracentrally in the PEX group
and 45 and 20 lm2, respectively, in the nonPEX
group (Table 2). In our study no preoperative dif-
ferences were found between the two groups in the
coefficients of variation (standard deviation/average
cell size� 100). The postoperative (24 hour) increase
of CV indicated a temporary heterogeneity of cell size
after surgery that returned near to the baseline value
during 1 month (Table 2). Corneal thickness did not
differ significantly between the two groups preoper-
atively. On the first postoperative day the thickness of
the central as well as the paracentral cornea was sig-
nificantly increased in both groups, indicating oede-
ma. The thickness of the cornea had returned to the
preoperative state 1 month after the operation
(Table 2).
Operation parameters are provided in Table 3.
Although the PEX group showed longer operation
time and more phaco power than the nonPEX group,
the difference between the two groups was not
statistically significant. Also the difference in overall
phaco impact between the two groups was not sig-
nificant. Consumption of BSS and phaco time showed
significant differences between the groups (p = 0.001
and p = 0.05, respectively).
In regression analysis the consumption of BSS and
phaco time variables did not have a statistically sig-
nificant influence on ECD 1 month after surgery.
Regression analysis revealed that phaco power had a
significant negative impact on ECD (centrally
r2 = 0.47, p = 0.02; paracentrally r2 = 0.39,
p<0.001). PEX as the main effect or in interaction
with phaco power did not have an influence on
endothelial cell loss (p = 0.2). There was also a sig-
nificant influence of overall phaco impact on overall
ECD (central + 4 paracentral) decline (r2 = 0.30,
p = 0.02). PEX in interaction with overall phaco
impact had a significant influence on endothelial cell
loss (r2 = 0.27, p = 0.05).
A statistically significant negative association be-
tween the age of patients and the postoperative cen-
tral as well as overall ECD 1 month after surgery was
found in regression analysis in this study (r2 = 0.47,
p = 0.004 and r2 = 0.45, p = 0.004, respectively).
Presence of PEX did not have an impact on ECD in
interaction with age (p = 0.7).
Between the preoperative ECD and the change in
ECD there was also a statistically significant negative
association in regression analysis, indicating that, the
larger the preoperative cell density, the larger the
postoperative cell loss (r = 0.45, p<0.001). PEX did
not have influence to postoperative ECD in interac-
tion with preoperative ECD (p = 0.5).
TABLE 3
Operation Parameters of the Study Groups
Variable PEX group (±SD) nonPEX group (±SD) p
Oper. time, minutes 12.4 (±4.3) 11.1 (±2.9) 0.2
Phaco power, % 44.0 (±13.2) 41.0 (±16.6) 0.5
Phaco time, seconds 92 (±44) 71 (±32) 0.05
Overall phaco impact 25.96 20.8 0.2
BSS, mm 26.8 (±7.1) 19.8 (±7.5) 0.001
PEX = patients with exfoliation.
nonPEX = patients without exfoliation.
BSS = balanced salt solution.
Overall phaco impact = phaco power multiplied by phaco time.
ANN OPHTHALMOL. 2007;39 (4) ..............................................331
DISCUSSION
Exfoliation syndrome is a common clinical feature in
patients with cataract (20,21). Because of insufficient
mydriasis and zonular weakness patients with PEX
are more susceptible to intraoperative complications
(4,9). It is also assumed that patients with PEX are
more susceptible to endothelial decompensation after
intraocular procedures.
Several studies have demonstrated quantitative or
qualitative morphological changes in corneal endo-
thelium in patients with exfoliation syndrome
(11,18,21,22). These studies have reported a reduc-
tion of the central ECD ranging from 10% to 21%. It
has been suggested that corneal endothelium metab-
olism is unsettled in eyes with exfoliation syndrome
inducing a loss of endothelium cells. On the other
hand, Puska et al. (12) did not find quantitative or
qualitative morphological changes in corneal endo-
thelium comparing the cornea in both eyes of patients
with unilateral PEX. They also found that normo-
tensive eyes with PEX had higher values of central
corneal thickness (CCT) and IOP. In contrast, Inoue
(22) found the CCT in PEX eyes to be significantly
thinner than that of the controls. Stefaniotou et al.
(23) in turn found significantly lower cell density and
thicker cornea in the PEX group than in the controls
but there was no difference between the eyes with
PEX and normal fellow eyes. In our study the mean
preoperative ECD as well as corneal thickness values
did not differ significantly between the PEX and
nonPEX groups. No significant differences between
the groups in CCT were found in all stages of this
study. In the first postoperative day a significant in-
crease of CCT was recorded due to corneal edema but
there was no significant difference between the values
of CCT at baseline and after 1 month. Similarly to
many other studies (22,24) we did not find a corre-
lation in the regression analysis between endothelial
cell loss and CCT.
Several studies have found that corneal endothelial
cells have decreased cell density, an increased CV of
cell area, and a decreased percentage of hexagonal
cells with increasing age (1,22). Age has also been
found to be an important variable to relevant to ECD
in cataract surgery (13,15). It is well known that the
prevalence of PEX increases with age (4,7,25). In our
study, as in a number of previous investigations
(4,6,7,21), patients with PEX were significantly older
than the controls because of the method of recruit-
ment. To evaluate the influence of aging and PEX to
ECD we performed regression analysis with age and
PEX as covariates. We found that in both groups age
of the subject was the most significant factor associ-
ated with higher cell loss during cataract surgery
independently of PEX or other variables.
In our study the cornea was more affected centrally
as well as paracentrally in the PEX group than in the
nonPEX group 1 month after the operation, but the
difference between the two groups had a statistically
weak significance (Table 2). Moreover, age but not
PEX, as the most influential preoperative factor,
seems to take credit for this difference. One could, of
course, speculate that in elderly people the synergy of
aging and exfoliation syndrome might lead to pro-
nounced metabolic disturbances of corneal endothe-
lium due to the effects overlapping. The differences in
corneal endothelium between PEX and nonPEX eyes
might therefore be more obvious in the elderly, but
further studies are needed to clarify this issue.
The relationship between endothelial cell loss and
morphometric parameters of the eye as well as
parameters of surgical procedure have been evaluated
in several studies. Walkow and colleagues (14) found
the to be an important factor in cell loss only when
correlated with lens thickness and longer operation
time. They also found a significant correlation be-
tween endothelial cell loss and axial length, but not
between endothelial cell loss and ACD. In contrast,
Kuchle et al. (15) found a significant relationship in
cataract surgery between ACD and endothelial cell
loss in patients with PEX but not between AL and
ECD. In our study no correlation between AL, ACD,
keratometry, lens thickness, and pre- and postopera-
tive ECD was found. Although shallow anterior
chamber and short axial length could dispose reduc-
tion of endothelial cells in cataract surgery, we believe
that surgeon technique and the phaco settings used
are more important.
In this study among intraoperative parameters, the
only significant variable for ECD loss was phaco
power. The presence of PEX did not affect ECD in
regression analysis. Walkow and colleagues (14)
found phaco time to be the most significant intraop-
erative factor in endothelial cell loss. Wirbelauer and
colleagues (11) did not find differences in phaco time
and power between PEX and nonPEX patients, and
neither variable had an influence on ECD in their
study. In our study there was a significant difference
between the two groups in phaco time, which could be
explained by more-cautious surgical technique in
PEX eyes due to insufficient mydriasis and zonular
weakness. We did not find a direct relationship
ANN OPHTHALMOL. 2007;39 (4) ..............................................332
between phaco time and ECD, but time became sig-
nificant in interaction with phaco power. Moreover, in
regression analysis PEX in interaction with overall
phaco impact (phaco time multiplied by power) had a
significant influence on endothelial cell loss. This
indicates that PEX in cases with high phaco impact
(e.g., hard nucleus) significantly increases the risk of
endothelial cell loss.
Similarly to other studies (7,26) we found signifi-
cant rise of IOP in the first postoperative day that
returned to the baseline value during 1 month. Po-
hjanen and colleagues (7) found normalized IOP
1 week after cataract surgery. Patients with PEX had
a tendency to postoperative rise of IOP but not sig-
nificantly compared to the control group. IOP post-
operative peak is transient and does not have a
significant influence on endothelial cell damage.
Regression analysis of our data showed that pre- and
postoperative IOP did not have an effect on ECD in
either group.
In summary, we found age to be the most impor-
tant parameter in endothelial cell loss in patients with
and without PEX. Phaco power was the most
important intraoperative variable for endothelial cell
loss. Although endothelial cell loss was more ex-
pressed in the PEX than in the nonPEX group, a
statistically significant negative correlation was
determined only in interaction with the overall phaco
impact. An experienced surgeon using highly adhesive
viscoelastic should operate in cases of presumably
prolonged operation time on eyes with a hard nucleus
and PEX.
REFERENCES
1. Abib FC, Barreto J. Jr. Behavior of corneal endothelial density
over a lifetime. J Cataract Refract Surg 2000;27:1574–1578.
2. Murphy C, Alvarado J, Juster R, Maglio M. Prenatal and post-
natal cellularity of the human corneal endothelium. A quantita-
tive histologic study. Invest Ophthalmol Vis Sci 1984;25:312–322.
3. Joyce NC. Proliferative capacity of the corneal endothelium. Prog
Retin Eye Res 2003;22:359–389.
4. Scorolli L, Scorolli L, Campos EC, Bassein L, Meduri RA.
Pseudoexfoliation syndrome: a cohort study on intraoperative
complications in cataract surgery. Ophthalmologica
1998;212:278–280.
5. Hayashi H, Hayashi K, Nakao F, Hayashi F. Anterior capsule
contraction and intraocular lens dislocation in eyes with pseu-
doexfoliation syndrome. Br J Ophthalmol 1998;82:1429–1432.
6. Shingleton BJ, Heltzer J, O’Donoghue MW. Outcomes of phac-
oemulsification in patients with and without pseudoexfoliation
syndrome. J Cataract Refract Surg 2003;29:1080–1086.
7. Pohjalainen T, Vesti E, Uusitalo RJ, Laatikainen L. Intraocular
pressure after phacoemulsification and intraocular lens implan-
tation in nonglaucomatous eyes with and without exfoliation.
J Cataract Refract Surg 2001;27:426–431.
8. Guzek JP, Holm M, Cotter JB, Cameron JA, Rademaker WJ,
Wissinger DH, Tonjin AM, Sleeper LA. Risk factors for intra-
operative complications in 1000 extracapsular cataract cases.
Ophthalmology 1987;94:461–466.
9. Skuta GL, Parrish RK II, Hodapp E, Forster RK, Rockwood EJ.
Zonular dialysis during extracapsular cataract extraction in
pseudoexfoliation syndrome. Arch Ophthalmol 1987;105:632–
634.
10. Lumme P, Laatikainen L. Exfoliation syndrome and cataract
extraction. Am J Ophthalmol 1993;116:51–55.
11. Wirbelauer C, Anders N, Pham DT, Wollensak J. Corneal
endothelial cell changes in pseudoexfoliation syndrome after
cataract surgery. Arch Ophthalmol 1998;116:145–149.
12. Puska P, Vasara K, Harju M, Setala K. Corneal thickness and
corneal endothelium in normotensive subjects with unilateral
exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol
2000;238:659–663.
13. Inoue K, Tokuda Y, Inoue Y, Amano S, Oshika T, Inoue J.
Corneal endothelial cell morphology in patients undergoing cat-
aract surgery. Cornea 2002;21:360–363.
14. Walkow T, Anders N, Klebe S. Endothelial cell loss after phac-
oemulsification: relation to preoperative and intraoperative
parameters. J Cataract Refract Surg 2000;26:727–732.
15. Kuchle M, Viestenz A, Martus P, Handel A, Junemann A,
Naumann GOH. Anterior chamber depth and complications
during cataract surgery in eyes with pseudoexfoliation syndrome.
Am J Ophthalmol 2000;129:281–285.
16. Bovelle R, Kaufman SC, Thompson HW, Hamano H. Corneal
thickness measurements with the Topcon SP-2000P specular
microscope and an ultrasound pachymeter. Arch Ophthalmol
1999;117:868–870.
17. Modis L Jr, Langenbucher A, Seitz B. Corneal endothelial cell
density and pachymetry measured by contact and noncontact
specular microscopy. J Cataract Refract Surg 2002;28:1763–1769.
18. Wirbelauer C, Anders N, Pham DT, Holschbach A, Wollensak J.
[Early postoperative endothelial cell loss after corneoscleral
tunnel incision and phacoemulsification in pseudoexfoliation
syndrome]. Der Ophthalmologe 1997;94:332–336.
19. Milla E, Verges C, Cipres M. Corneal endothelium evaluation
after phacoemulsification with continous anterior chamber infu-
sion. Cornea 2005;24:278–282.
20. Puska P, Tarkkanen A. Five-year follow-up of lens opacities in
exfoliation syndrome. J Cataract Refract Surg 2001;27:1992–
1998.
21. Kaljurand K, Puska P. Exfoliation syndrome in Estonian
patients scheduled for cataract surgery. Acta Ophthalm Scand
2004;82:259–263.
22. Inoue K, Okugawa K, Oshika T, Amano S. Morphological study
of corneal endothelium and corneal thickness in pseudoexfolia-
tion syndrome. Jpn J Ophthalmol 2003;47:235–239.
23. Stefaniotou M, Kalogeropoulos C, Razis N, Psilas K. The cornea
in exfoliation syndrome. Doc Ophthalmol 1992;80:329–333.
24. Sobottka Ventura AC, Walti R, Bohnke M. Corneal thickness
and endothelial density before and after cataract surgery. Br J
Ophthalmol 2001;85:18–20.
25. Tarkkanen AHA. Exfoliation syndrome. Trans Ophthalmol Soc
UK 1986;105:233–236.
26. Lagreze WD, Bomer TG, Funk J. Effect of surgical technique on
the increase in intraocular pressure after cataract extraction.
Ophthalmic Surg Lasers 1996;27:169–173.
ANN OPHTHALMOL. 2007;39 (4) ..............................................333